Utility of circulating tumor DNA methylation biomarkers in newly diagnosed prostate cancer
Main Authors: | M.T. Bjerre, M. Nørgaard, O.H. Larsen, S.Ø. Jensen, P. Østergreen, M. Fode, J. Fredsøe, B. Ulhøi, M.M. Mortensen, J.B. Jensen, M. Borre, K.D. Sørensen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320337186 |
Similar Items
-
Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential
by: Marianne Trier Bjerre, et al.
Published: (2020-05-01) -
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
by: Marianne T. Bjerre, et al.
Published: (2019-03-01) -
Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential
by: Jacob Fredsøe, et al.
Published: (2020-03-01) -
Cytokine profile in children with newly diagnosed tuberculosis
by: O. M. Raznatovska, et al.
Published: (2017-10-01) -
Adjuvant Treatment of Newly Diagnosed Breast Cancer
by: Bossaer, John B., et al.
Published: (2011)